Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Andrew, Bacon"'
Autor:
Jeff Drew, Raymond C.B. Wong, Brett Morimoto, Shahrooz Rabizadeh, Peter A. Sieling, Lennie Sender, Pete Bone, Daniel C. Sanford, Patrick Soon-Shiong, Andrew Bacon, Victor Peykov, Patricia Spilman, Adrian Rice, Jeffrey T. Safrit, Mohit Verma, Lise Zakin, Joseph P. Balint, Kyle Dinkins, Hermes Garban, Ashish Bezawada, Kayvan Niazi, Annie Shin, Philip T. Liu, Helty Adisetiyo, Elizabeth Gabitzsch
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
We have developed a dual-antigen COVID-19 vaccine incorporating genes for a modified SARS-CoV-2 spike protein (S-Fusion) and the viral nucleocapsid (N) protein with an Enhanced T-cell Stimulation Domain (N-ETSD) to increase the potential for MHC clas
Publikováno v:
Infection and Immunity. 67:3810-3815
We have investigated the effect of preexisting immunity to homologous ( Salmonella typhimurium ) or heterologous ( S. dublin ) serotypes of Salmonella on the ability of an attenuated S. typhimurium aroA aroD vector (BRD509) to immunize mice against t
Autor:
Matthew Bentley, Edward Cahill, Mark Page, Steven N. Chatfield, Christopher D Jones, Andrew Bacon
Publikováno v:
Vaccine. 17:2528-2537
The incidence of non-responders to hepatitis B (HB) virus SHBs antigen (Ag) vaccines has prompted the development of pre-S containing vaccines. The aim of this study was to characterise the murine immune response to a novel recombinant particle (Hepa
Publikováno v:
Journal of Viral Hepatitis. 5:5-8
Hepagene is a novel recombinant particle consisting of the pre-S1, pre-S2 and small surface (SHBs) antigens (Ag) of the hepatitis B virus (HBV) and is adjuvanted with alhydrogel in the final formulation. It has been primarily developed to enhance ant
Publikováno v:
PLoS ONE, Vol 3, Iss 6, p e2368 (2008)
PLoS ONE
PLoS ONE
Background\ud \ud Antibody against CD40 is effective in enhancing immune responses to vaccines when chemically conjugated to the vaccine antigen. Unfortunately the requirement for chemical conjugation presents some difficulties in vaccine production
Autor:
Michael Hinchcliffe, Inderjit Jabbal-Gill, Steven N. Chatfield, Lisbeth Illum, P. J. Sizer, J. Makin, Mark Roberts, Andrew Bacon
Publikováno v:
Infection and immunity. 68(10)
We have evaluated the ability of two carbohydrate biopolymers, chitosan and gellan, to enhance antibody responses to subunit influenza virus vaccines delivered to the respiratory tracts of mice. Groups of mice were vaccinated three times intranasally
Autor:
G. Dougan, Rino Rappuoli, M Marinaro, I. Cropley, Steven N. Chatfield, Mark L. Roberts, J McGhee, Gillian Douce, Andrew Bacon, M Pizza
Publikováno v:
Scopus-Elsevier
We examined the capacity of a genetically detoxified derivative of pertussis toxin (PTX), PT-9K/129G, to act as a mucosal adjuvant for an intranasally (i.n.) administered tetanus vaccine. Groups of mice were immunized i.n. with the nontoxic C-termina
Publikováno v:
Scopus-Elsevier
We have found the in vivo-regulated nirB promoter (P nirB ) to be effective for directing expression of a number of antigens in salmonella in vivo. We wished to determine if other in vivo-regulated promoters have utility for antigen expression in sal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1553cc559eadc97cb640fcc2188acc4
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031814272&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-0031814272&partnerID=MN8TOARS